1. Home
  2. GERN vs USA Comparison

GERN vs USA Comparison

Compare GERN & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GERN
  • USA
  • Stock Information
  • Founded
  • GERN 1990
  • USA 1986
  • Country
  • GERN United States
  • USA United States
  • Employees
  • GERN N/A
  • USA N/A
  • Industry
  • GERN Biotechnology: Pharmaceutical Preparations
  • USA Finance Companies
  • Sector
  • GERN Health Care
  • USA Finance
  • Exchange
  • GERN Nasdaq
  • USA Nasdaq
  • Market Cap
  • GERN 2.5B
  • USA 2.0B
  • IPO Year
  • GERN 1996
  • USA N/A
  • Fundamental
  • Price
  • GERN $2.89
  • USA $7.13
  • Analyst Decision
  • GERN Strong Buy
  • USA
  • Analyst Count
  • GERN 10
  • USA 0
  • Target Price
  • GERN $7.15
  • USA N/A
  • AVG Volume (30 Days)
  • GERN 14.8M
  • USA 880.5K
  • Earning Date
  • GERN 02-26-2025
  • USA 01-01-0001
  • Dividend Yield
  • GERN N/A
  • USA 9.66%
  • EPS Growth
  • GERN N/A
  • USA N/A
  • EPS
  • GERN N/A
  • USA N/A
  • Revenue
  • GERN $29,480,000.00
  • USA N/A
  • Revenue This Year
  • GERN $31,478.06
  • USA N/A
  • Revenue Next Year
  • GERN $290.89
  • USA N/A
  • P/E Ratio
  • GERN N/A
  • USA N/A
  • Revenue Growth
  • GERN 9199.68
  • USA N/A
  • 52 Week Low
  • GERN $1.64
  • USA $5.62
  • 52 Week High
  • GERN $5.34
  • USA $7.09
  • Technical
  • Relative Strength Index (RSI)
  • GERN 25.84
  • USA 54.66
  • Support Level
  • GERN $2.80
  • USA $6.80
  • Resistance Level
  • GERN $3.68
  • USA $7.17
  • Average True Range (ATR)
  • GERN 0.18
  • USA 0.10
  • MACD
  • GERN -0.04
  • USA 0.02
  • Stochastic Oscillator
  • GERN 10.23
  • USA 82.50

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

About USA Liberty All-Star Equity Fund

Liberty All Star Equity Fund is a closed-end funds and open-end multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing primarily in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication and other services.

Share on Social Networks: